We are live on
!
Find out more
FIM
Fernwood Investment Management Portfolio holdings
AUM
$288M
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+7.86%
1 Year Est. Return
+33.54%
3 Year Est. Return
+83.37%
5 Year Est. Return
+196.85%
10 Year Est. Return
+650.16%
AUM
$237M
AUM Growth
+$5.04M
(+2.2%)
Cap. Flow
+$1M
Cap. Flow
% of AUM
0.42%
Top 10 Holdings %
Top 10 Hldgs %
30.59%
Holding
188
New
5
Increased
37
Reduced
65
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$1.3M |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$1M |
| 3 |
Horizon Kinetics Inflation Beneficiaries ETF
INFL
|
+$604K |
| 4 |
Jasper Therapeutics
JSPR
|
+$544K |
| 5 |
Alphatec Holdings
ATEC
|
+$293K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$1.55M |
| 2 |
iShares Select Dividend ETF
DVY
|
+$276K |
| 3 |
Procter & Gamble
PG
|
+$220K |
| 4 |
State Street SPDR Portfolio Emerging Markets ETF
SPEM
|
+$210K |
| 5 |
Texas Pacific Land
TPL
|
+$206K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.2% |
| 2 | Technology | 11.29% |
| 3 | Energy | 9.28% |
| 4 | Consumer Discretionary | 7.73% |
| 5 | Financials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
N-able
NABL
$612M
| $139K | 0.06% |
15,100
| – | – |
|
177
Palantir
PLTR
$411B
| $119K | 0.05% |
14,650
-300
| -2% | -$2.67K |
|
178
Cognyte Software
CGNT
$675M
| $93K | 0.04% |
22,950
| – | – |
|
|
JNCE
179
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $75K | 0.03% |
32,259
| – | – |
|
180
Invesco Senior Income Trust
VVR
$457M
| $67K | 0.03% |
18,035
| – | – |
|
|
CISO
181
CISO Global
CISO
$11.8M
| $59K | 0.02% |
1,333
| – | – |
|
|
QVCGA
182
DELISTED
QVC Group Inc Series A
QVCGA
| $40K | 0.02% |
400
| – | – |
|
|
DHF
183
BNY Mellon High Yield Strategies Fund
DHF
$175M
| $35K | 0.01% |
16,400
| – | – |
|
|
LX
184
LexinFintech Holdings
LX
$237M
| $19K | 0.01% |
11,500
| – | – |
|
|
AWH
185
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $4K | ﹤0.01% |
667
| – | – |
|
|
186
Procter & Gamble
PG
$335B
| – | – |
-1,527
| Closed | -$220K |
|
|
187
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.7B
| – | – |
-6,044
| Closed | -$210K |
|
|
AVYA
188
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| – | – |
-11,100
| Closed | -$25K |
|
Similar funds
CIM
CSWM
WWP
GWM
FWM
MWS
AP
AA
Fernwood Investment Management's Q3 2022 Portfolio in Review
As of Q3 2022, Fernwood Investment Management held 188 positions worth $237M, up 2.2% from $232M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 4.3%. Fernwood Investment Management opened 5 new positions and exited 3, leaving the 188-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Energy.
- Fernwood Investment Management's largest Q3 2022 buy was Kellanova: 18,873 shares worth $1.23M.
- Fernwood Investment Management added most to Alphatec Holdings in Q3 2022, an estimated $293K increase.
- Fernwood Investment Management's biggest Q3 2022 reduction was Global Blood Therapeutics, Inc., cutting an estimated $1.55M.
- Fernwood Investment Management fully exited Procter & Gamble in Q3 2022, selling an estimated $220K.
- Fernwood Investment Management's ten largest holdings make up 31% of its $237M portfolio in Q3 2022.
- Fernwood Investment Management opened 5 new positions and closed 3 in Q3 2022.
- Fernwood Investment Management's portfolio value rose 2.2% quarter-over-quarter to $237M.
Based on Fernwood Investment Management's 13F filing for Q3 2022, filed 9 Nov 2022.